ASAS40 and ASDAS clinical responses in the ABILITY-1 clinical trial translate to meaningful improvements in physical function, health-related quality of life and work productivity in patients with non-radiographic axial spondyloarthritis

axial spondyloarthritisankylosissacroiliitismagnetic resonance imagingadalimumabhealth-related quality of lifeactivities of daily livingwork productivity